Cytosorbents (CTSO) Misses Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
CytoSorbents (CTSO) PT Raised to $16.50 at B.Riley/FBR
August 3, 2018 9:20 AM EDTB.Riley/FBR raised its price target on CytoSorbents (NASDAQ: CTSO) to $16.50 (from $13.00) while maintaining a Buy rating.
... MoreCytoSorbents (CTSO) PT Raised to $18 at Maxim Group
August 3, 2018 7:36 AM EDTMaxim Group raised its price target on CytoSorbents (NASDAQ: CTSO) to $18.00 (from $13.00) while maintaining a Buy rating.
Analsyt Jason McCarthy commented:
Cytosorbents reported another quarter of growth with Cytosorb revenues of $5.24M, up sequentially from $4.4Mthe 24th consecutive quarter of y/y... MoreCytoSorbents (CTSO) PT Raised to $15 at Cowen
August 3, 2018 6:42 AM EDTCowen raised its price target on CytoSorbents (NASDAQ: CTSO) to $15.00 (from $13.00) while maintaining an Outperform rating.
Analyst Josuah Jennings commented, "CTSO again delivered impressive quarterly revenue growth, with product sales of $5.2M, up 72% from last year. Lead product CytoSorb has numerous tailwinds in 2018, including (1) favorable German... More
